Discover our journey, strategic vision, and state-of-the-art facility driving global pharmaceutical pellet manufacturing.
Scoat Pharma Private Limited was incorporated in 2006 with a strong vision to become a symbol of trust in innovative developing, manufacturing, and exporting Pharmaceutical pellets. We are proud to be co-promoted by the prestigious Suraksha Group.
Innovation is an ongoing process at Scoat Pharma. Our core objective is to provide mankind with top-class quality products for a better quality of life as we develop advanced pellet technologies.
We specialize in customized development and manufacturing of Immediate Release Pellets / Modified Release Pellets / Enteric Coated Pellets / Retard Micro Granules of various Active Pharmaceutical Ingredients (APIs) including different combination blends in **Ready-To-Fill** form.
In 2025, marking a significant milestone in our growth journey, we relocated our manufacturing facility to a more advanced setup. This strategic move has significantly enhanced our production capacity and operational efficiency, perfectly positioning our company for greater exposure and expansion in both domestic and global markets.
Scoat Pharma is driven by a committed team dedicated to quality, precision, and continuous improvement. We ensure that every product we manufacture reflects the highest levels of efficacy.
Certified Standards
100% supply responsibility
A dynamic technopreneur with over 30 years of deep industry experience cross-cutting Research & Development, Manufacturing, Quality Assurance, and Regulatory Affairs. Having worked closely with several leading global pharmaceutical enterprises, including Dr. Reddy's Laboratories, he commands a profound mastery of Formulation Development, complex Plant Operations, and stringent international Regulatory frameworks.
Integrating innovation, efficiency, and sustainability to unlock business performance while maintaining full technical, regulatory, and compliance support for global clients.